user

In silico prioritization for endocrine active substances (EAS) and their in vitro validation

被引：0
|
作者：
Eberini, I. [1 ]
Palazzolo, L. [2 ]
Peijnenburg, A. [3 ]
Guerrini, U. [1 ]
Parravicini, C. [1 ]
Moretto, A. [2 ]
Bovee, T. [3 ]
机构：
[1] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy
[2] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Milan, Italy
[3] Wageningen Univ, RIKILT Inst Food Safety, Wageningen, Netherlands
来源：
TOXICOLOGY LETTERS | 2016年 / 258卷
关键词：
D O I：
10.1016/j.toxlet.2016.06.1486
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P05-018
引用
收藏
页码：S120 / S120
页数：1
相关论文
共 50 条
  • [21] Ecotoxicological Hazard and Risk Assessment of Endocrine Active Substances
    Leopold, Annegaaike
    Roberts, Mike
    Matthiessen, Peter
    INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT, 2017, 13 (02) : 264 - 266
  • [22] In vitro validation of in silico identified inhibitory interactions
    Liu, Honglei
    Bridges, Daniel
    Randall, Connor
    Solla, Sara A.
    Wu, Bian
    Hansma, Paul
    Yan, Xifeng
    Kosik, Kenneth S.
    Bouchard, Kristofer
    JOURNAL OF NEUROSCIENCE METHODS, 2019, 321 : 39 - 48
  • [23] Cuminaldehyde as a Lipoxygenase Inhibitor: In Vitro and In Silico Validation
    Tomy, M. J.
    Dileep, K. V.
    Prasanth, S.
    Preethidan, D. S.
    Sabu, A.
    Sadasivan, C.
    Haridas, M.
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2014, 174 (01) : 388 - 397
  • [24] Cuminaldehyde as a Lipoxygenase Inhibitor: In Vitro and In Silico Validation
    M. J. Tomy
    K. V. Dileep
    S. Prasanth
    D. S. Preethidan
    A. Sabu
    C. Sadasivan
    M. Haridas
    Applied Biochemistry and Biotechnology, 2014, 174 : 388 - 397
  • [25] Validation of the yeast estrogen and yeast androgen screens for endocrine active substances: Inter-laboratory ring trial
    Ramirez, Tzutzuy
    Woitkowiak, Claudia
    Huener, Hans-Albrecht
    Schoenlau, Christine
    Hollert, Henner
    Broschk, Susanne
    Zierau, Oliver
    Vollmer, Guenter
    Jaeger, Martina
    Poth, Albrecht
    Higley, Eric
    Hecker, Markus
    van Ravenzwaay, Ben
    Landsiedel, Robert
    TOXICOLOGY LETTERS, 2013, 221 : S217 - S217
  • [26] Validation of the Yeast Estrogen and Yeast Androgen Screens for Endocrine Active Substances: Inter-laboratory ring trial
    Ramirez, T.
    Woitkowiak, C.
    Huener, H. -A
    Schoenlau, C.
    Hollert, H.
    Broschk, S.
    Zierau, O.
    Vollmer, G.
    Poth, A.
    Jaeger, M.
    Higley, E.
    Hecker, M.
    van Ravenzwaay, B.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S65 - S65
  • [27] Integrated in silico and in vitro genotoxicity assessment of thirteen datapoor substances
    Tran, Yen K.
    Buick, Julie K.
    Keir, Jennifer L. A.
    Williams, Andrew
    Swartz, Carol D.
    Recio, Leslie
    White, Paul A.
    Lambert, Iain B.
    Yauk, Carole L.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2019, 107
  • [28] Incorporation of a Metabolizing System in Biodetection Assays for Endocrine Active Substances
    Mollergues, Julie
    van Vugt-Lussenburg, Barbara
    Kirchnawy, Christian
    Bandi, Reka Anna
    van der Lee, Rosan B.
    Marin-Kuan, Maricel
    Schilter, Benoit
    Fussell, Karma C.
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2017, 34 (03) : 389 - 398
  • [29] Endocrine-active substances in food: identification, evaluation, and control
    Luo, Yu-Syuan
    Ye, Xiaoqing
    Yin, Shanshan
    FRONTIERS IN NUTRITION, 2023, 10
  • [30] The endocrine and reproductive system: Adverse effects of hormonally active substances?
    Greim, HA
    PEDIATRICS, 2004, 113 (04) : 1070 - 1075
12345